4//SEC Filing
Seltzer Stacey Denenberg 4
Accession 0000899243-18-013931
CIK 0001631650other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:09 PM ET
Size
7.7 KB
Accession
0000899243-18-013931
Insider Transaction Report
Form 4
Seltzer Stacey Denenberg
Director
Transactions
- Award
Common Stock, $0.0001 par value
2018-05-23+3,750→ 3,779 total - Award
Stock Option (right to buy)
2018-05-23+7,500→ 7,500 totalExercise: $32.79Exp: 2028-05-23→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
- [F2]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001648895
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:09 PM ET
- Size
- 7.7 KB